Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2019 6
2020 6
2021 12
2022 15
2023 22
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories.
Placido D, Yuan B, Hjaltelin JX, Zheng C, Haue AD, Chmura PJ, Yuan C, Kim J, Umeton R, Antell G, Chowdhury A, Franz A, Brais L, Andrews E, Marks DS, Regev A, Ayandeh S, Brophy MT, Do NV, Kraft P, Wolpin BM, Rosenthal MH, Fillmore NR, Brunak S, Sander C. Placido D, et al. Among authors: fillmore nr. Nat Med. 2023 May;29(5):1113-1122. doi: 10.1038/s41591-023-02332-5. Epub 2023 May 8. Nat Med. 2023. PMID: 37156936 Free PMC article.
Brain tumors in United States military veterans.
Bihn JR, Cioffi G, Waite KA, Kruchko C, Neff C, Price M, Ostrom QT, Swinnerton KN, Elbers DC, Mooney MA, Rachlin J, Stein TD, Brophy MT, Do NV, Ferguson RE, Priemer DS, Perl DP, Hickman RA, Nabors B, Rusiecki J, Barnholtz-Sloan JS, Fillmore NR. Bihn JR, et al. Among authors: fillmore nr. Neuro Oncol. 2024 Feb 2;26(2):387-396. doi: 10.1093/neuonc/noad182. Neuro Oncol. 2024. PMID: 37738677
More intensive therapy as more effective treatment for frail patients with multiple myeloma [corrected].
DuMontier C, La J, Bihn J, Corrigan J, Yildirim C, Dharne M, Hassan H, Yellapragada S, Abel GA, Gaziano JM, Do NV, Brophy M, Kim DH, Munshi NC, Fillmore NR, Driver JA. DuMontier C, et al. Among authors: fillmore nr. Blood Adv. 2023 Oct 24;7(20):6275-6284. doi: 10.1182/bloodadvances.2023011019. Blood Adv. 2023. PMID: 37582048 Free PMC article. Clinical Trial.
Evaluating the impact of age on immune checkpoint therapy biomarkers.
Erbe R, Wang Z, Wu S, Xiu J, Zaidi N, La J, Tuck D, Fillmore N, Giraldo NA, Topper M, Baylin S, Lippman M, Isaacs C, Basho R, Serebriiskii I, Lenz HJ, Astsaturov I, Marshall J, Taverna J, Lee J, Jaffee EM, Roussos Torres ET, Weeraratna A, Easwaran H, Fertig EJ. Erbe R, et al. Among authors: fillmore n. Cell Rep. 2021 Aug 24;36(8):109599. doi: 10.1016/j.celrep.2021.109599. Cell Rep. 2021. PMID: 34433020 Free PMC article.
Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems.
Li A, La J, May SB, Guffey D, da Costa WL Jr, Amos CI, Bandyo R, Milner EM, Kurian KM, Chen DCR, Do NV, Granada C, Riaz N, Brophy MT, Chitalia V, Gaziano JM, Garcia DA, Carrier M, Flowers CR, Zakai NA, Fillmore NR. Li A, et al. Among authors: fillmore nr. J Clin Oncol. 2023 Jun 1;41(16):2926-2938. doi: 10.1200/JCO.22.01542. Epub 2023 Jan 10. J Clin Oncol. 2023. PMID: 36626707 Free PMC article.
64 results